Biotechnology
Technology
Health

Kadmon

$2.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-3.49%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Kadmon and other stocks, options, ETFs, and crypto commission-free!

About

Kadmon Holdings, Inc., also called Kadmon, is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics. It focuses on the treatment of autoimmune, inflammatory, and fibrotic diseases. Read More Its products include Ribasphere, RibaPak, Tetrabenazine, Valganciclovir, Abacavir, Entecavir, Lamivudine, and Zidovudine. The company was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY.

Employees
116
Headquarters
New York, New York
Founded
2010
Market Cap
290.62M
Price-Earnings Ratio
Dividend Yield
Average Volume
828.12K
High Today
$2.27
Low Today
$2.20
Open Price
$2.26
Volume
52.85K
52 Week High
$4.39
52 Week Low
$1.88

Collections

Biotechnology
Technology
Health
Biopharmaceutical
Pharmaceutical
2016 IPO
US
North America

News

Yahoo FinanceMay 9

Kadmon Provides Business Update and Reports First Quarter 2019 Financial Results

NEW YORK, NY / ACCESSWIRE / May 9, 2019 / Kadmon Holdings, Inc. (KDMN) today provided a business update and reported financial and operational results for the first quarter of 2019. ''The advancement of KD025 for the treatment of cGVHD continues to be Kadmon's key priority. We recently held a Type B Breakthrough Therapy meeting with the FDA and remain aligned with the Agency on our registration study design and the broader data package to support a potential New Drug Application,'' said Harlan W. Waksal, M...

29

Earnings

-$0.42
-$0.27
-$0.13
$0.02
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.16 per share
Actual
$0.02 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.